Autologous Cell Therapies

Autologous Cell Therapies

Global Autologous Cell Therapies Market to Reach $69.4 Billion by 2030
The global market for Autologous Cell Therapies estimated at US$21.9 Billion in the year 2023, is expected to reach US$69.4 Billion by 2030, growing at a CAGR of 15.5% over the period 2023-2030. Bone Marrow Source, one of the segments analyzed in the report, is expected to record 15.1% CAGR and reach US$31.9 Billion by the end of the analysis period. Growth in the Epidermis Source segment is estimated at 16.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.8 Billion, While China is Forecast to Grow at 14.8% CAGR
The Autologous Cell Therapies market in the U.S. is estimated at US$6.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.8 Billion by the year 2030 trailing a CAGR of 14.8% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.7% and 13.2% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 11.3% CAGR.

Introducing Our Exciting New Report Features for 2024
» Full access to influencer engagement stats
» Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
» Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
» Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
» Complimentary report updates for one year
» Competitor coverage with global market shares of major players
» Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
» Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 42 Featured) -
  • BioTime, Inc.
  • Brainstorm Cell Therapeutics, Inc.
  • Caladrius Biosciences, Inc.
  • Fibrocell Science, Inc.
  • Opexa Therapeutics, Inc.
  • Pharmicell Co., Ltd.
  • Regeneus Ltd.
  • TiGenix NV
  • TxCell S.A.
  • U.S. Stem Cell, Inc.
  • Vericel Corporation
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Autologous Cell Therapies – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Chronic Diseases Spurs Growth in Autologous Cell Therapies Market
Technological Advancements in Gene Editing Propel Innovation in Autologous Cell Therapies
Growing Demand for Personalized Medicine Expands Addressable Market for Autologous Cell Therapies
Increasing Investment in Biopharmaceutical Research Drives Adoption of Autologous Cell Therapies
Expansion of Therapeutic Applications for Autologous Therapies Drives Market Adoption
Growing Recognition of Autologous Therapies in Oncology Throws the Spotlight on New Treatments
Advancements in Cell Culture Techniques Sustain Growth in the Autologous Therapies Market
Next-Generation Sequencing and Diagnostics Propel Adoption of Autologous Cell Therapies
Growing Focus on Immune Disorders Expands Market Potential for Autologous Therapies
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Autologous Cell Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Autologous Cell Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Autologous Cell Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Bone Marrow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Bone Marrow by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Bone Marrow by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Epidermis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Epidermis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Epidermis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Other Sources by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Wound Healing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Wound Healing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Ambulatory Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 32: World Historic Review for Ambulatory Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 33: World 16-Year Perspective for Ambulatory Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 35: World Historic Review for Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 36: World 16-Year Perspective for Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 37: World Autologous Cell Therapies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: USA Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: USA 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Canada 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Canada 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
JAPAN
Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: Japan 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: Japan 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
CHINA
Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: China Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: China 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: China Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: China 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
EUROPE
Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Autologous Cell Therapies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Autologous Cell Therapies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: Europe 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
FRANCE
Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: France Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: France 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: France Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: France 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
GERMANY
Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Germany 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Germany 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: Italy 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: Italy 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
UNITED KINGDOM
Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: UK Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: UK 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: UK Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: UK 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Rest of Europe Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Rest of Europe 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Europe Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Europe 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Europe Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Europe 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Autologous Cell Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Asia-Pacific Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Asia-Pacific 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Asia-Pacific Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Asia-Pacific 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Asia-Pacific 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 140: Rest of World Recent Past, Current & Future Analysis for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Rest of World Historic Review for Autologous Cell Therapies by Source - Bone Marrow, Epidermis and Other Sources Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Rest of World 16-Year Perspective for Autologous Cell Therapies by Source - Percentage Breakdown of Value Sales for Bone Marrow, Epidermis and Other Sources for the Years 2014, 2024 & 2030
TABLE 143: Rest of World Recent Past, Current & Future Analysis for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of World Historic Review for Autologous Cell Therapies by Application - Neurology, Orthopedic, Cancer, Wound Healing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of World 16-Year Perspective for Autologous Cell Therapies by Application - Percentage Breakdown of Value Sales for Neurology, Orthopedic, Cancer, Wound Healing and Other Applications for the Years 2014, 2024 & 2030
TABLE 146: Rest of World Recent Past, Current & Future Analysis for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Rest of World Historic Review for Autologous Cell Therapies by End-Use - Hospitals, Ambulatory Centers and Research Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Rest of World 16-Year Perspective for Autologous Cell Therapies by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Centers and Research Centers for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings